Breakthroughs at Blueprint Medicines Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development engine. Blueprint’s drug development strategy was twofold-it focused on creating a single drug compound for multiple disease indications, while at the same time developing drugs to track a disease through its progression. The company’s goal was to become a fully integrated biopharmaceutical company that could move from drug discovery to development to marketing. But it was increasingly challenging to prioritize and manage programs, personnel and partnerships.
Learning Objective:
To appreciate the power and benefits of a precision medicine approach to drug development.
five-page double space assignment, without including references, graphs or charts as the overall page count.

Expert Help With This Assignment — On Your Terms